Skip to content
PICO Portalanswers from OpenAlex

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

PaperCitations, authors & open-access status

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents is a paper indexed in PICO Portal from OpenAlex.

How many citations does Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents have?

PICO Portalcitation count

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents has 1,865 citations in the OpenAlex counts PICO Portal stores.

When was Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents published?

PICO Portalyear

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents has 1977 year in the PICO Portal index.

What is the open-access status of Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents?

PICO Portaloa status

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents has closed oa status in the PICO Portal index.

What is the DOI of Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents?

PICO Portaldoi

The DOI for Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents is on the source record.

What is the PMID of Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents?

PICO Portalpmid

The PMID for Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents is on the source record.

What is the OpenAlex record for Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents?

PICO Portalopenalex

The OpenAlex for Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial